Home
/
CLOROX CO /DE/
/
Financials
/
Quarterly
CLOROX CO /DE/ — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that CLOROX CO /DE/ filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2019
Dec 31, 2018
$1.47B
Feb 4, 2019
Q1
2019
Sep 30, 2018
$1.56B
Oct 31, 2018
Q2
2019
Dec 31, 2017
$1.42B
Feb 4, 2019
Q1
2019
Sep 30, 2017
$1.50B
Oct 31, 2018
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2026
Dec 31, 2025
$1.67B
Feb 3, 2026
Q1
2026
Sep 30, 2025
$1.43B
Nov 3, 2025
Q3
2025
Mar 31, 2025
$1.67B
May 5, 2025
Q2
2026
Dec 31, 2024
$1.69B
Feb 3, 2026
Q1
2026
Sep 30, 2024
$1.76B
Nov 3, 2025
Q3
2025
Mar 31, 2024
$1.81B
May 5, 2025
Q2
2025
Dec 31, 2023
$1.99B
Feb 3, 2025
Q1
2025
Sep 30, 2023
$1.39B
Oct 30, 2024
Q3
2024
Mar 31, 2023
$1.92B
Apr 30, 2024
Q2
2024
Dec 31, 2022
$1.72B
Feb 1, 2024
Q1
2024
Sep 30, 2022
$1.74B
Nov 1, 2023
Q3
2023
Mar 31, 2022
$1.81B
May 2, 2023
Q2
2023
Dec 31, 2021
$1.69B
Feb 2, 2023
Q1
2023
Sep 30, 2021
$1.81B
Nov 1, 2022
Q3
2022
Mar 31, 2021
$1.78B
May 2, 2022
Q2
2022
Dec 31, 2020
$1.84B
Feb 3, 2022
Q1
2022
Sep 30, 2020
$1.92B
Nov 1, 2021
Q3
2021
Mar 31, 2020
$1.78B
Apr 30, 2021
Q2
2021
Dec 31, 2019
$1.45B
Feb 4, 2021
Q1
2021
Sep 30, 2019
$1.51B
Nov 2, 2020
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2018
Mar 31, 2018
$1.52B
May 2, 2018
Q2
2018
Dec 31, 2017
$1.42B
Feb 2, 2018
Q1
2018
Sep 30, 2017
$1.50B
Nov 1, 2017
Q3
2018
Mar 31, 2017
$1.48B
May 2, 2018
Q2
2018
Dec 31, 2016
$1.41B
Feb 2, 2018
Q1
2018
Sep 30, 2016
$1.44B
Nov 1, 2017
Q3
2017
Mar 31, 2016
$1.43B
May 3, 2017
Q2
2017
Dec 31, 2015
$1.35B
Feb 3, 2017
Q1
2017
Sep 30, 2015
$1.39B
Nov 2, 2016
Q3
2016
Mar 31, 2015
$1.40B
May 3, 2016
Q2
2016
Dec 31, 2014
$1.35B
Feb 4, 2016
Q1
2016
Sep 30, 2014
$1.35B
Nov 2, 2015
Q3
2015
Mar 31, 2014
$1.37B
May 4, 2015
Q2
2015
Dec 31, 2013
$1.31B
Feb 5, 2015
Q1
2015
Sep 30, 2013
$1.34B
Nov 3, 2014
Q3
2014
Mar 31, 2013
$1.41B
May 2, 2014
Q2
2014
Dec 31, 2012
$1.33B
Feb 5, 2014
Q1
2014
Sep 30, 2012
$1.34B
Nov 1, 2013
Q3
2013
Mar 31, 2012
$1.40B
May 2, 2013
Q2
2013
Dec 31, 2011
$1.22B
Feb 5, 2013
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2026
Dec 31, 2025
$157.00M
Feb 3, 2026
Q1
2026
Sep 30, 2025
$80.00M
Nov 3, 2025
Q3
2025
Mar 31, 2025
$186.00M
May 5, 2025
Q2
2026
Dec 31, 2024
$193.00M
Feb 3, 2026
Q1
2026
Sep 30, 2024
$99.00M
Nov 3, 2025
Q3
2025
Mar 31, 2024
($51.00M)
May 5, 2025
Q2
2025
Dec 31, 2023
$93.00M
Feb 3, 2025
Q1
2025
Sep 30, 2023
$22.00M
Oct 30, 2024
Q3
2024
Mar 31, 2023
($211.00M)
Apr 30, 2024
Q2
2024
Dec 31, 2022
$99.00M
Feb 1, 2024
Q1
2024
Sep 30, 2022
$85.00M
Nov 1, 2023
Q3
2023
Mar 31, 2022
$150.00M
May 2, 2023
Q2
2023
Dec 31, 2021
$69.00M
Feb 2, 2023
Q1
2023
Sep 30, 2021
$142.00M
Nov 1, 2022
Q3
2022
Mar 31, 2021
($61.00M)
May 2, 2022
Q2
2022
Dec 31, 2020
$259.00M
Feb 3, 2022
Q1
2022
Sep 30, 2020
$415.00M
Nov 1, 2021
Q3
2021
Mar 31, 2020
$241.00M
Apr 30, 2021
Q2
2021
Dec 31, 2019
$185.00M
Feb 4, 2021
Q1
2021
Sep 30, 2019
$203.00M
Nov 2, 2020